Risks of parenteral deferoxamine for acute iron poisoning.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Toxicology Clinical Toxicology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/15563659609028006PMID 8800186
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Survival after a severe iron poisoning treated with intermittent infusions of deferoxamine.

  1995cited by this paper
• Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies.

  1993cited by this paper
• Pulmonary toxicity of deferoxamine in iron-poisoned mice.

  1993cited by this paper
• Polymer conjugation reduces deferoxamine induced retinopathy in an albino rat model.

  1993cited by this paper
• Free radicals in toxicology.

  1993cited by this paper
• Intravenous infusion pharmacokinetics of desferrioxamine in thalassaemic patients.

  1993cited by this paper
• Iron: metabolism, toxicity and therapy.

  1993cited by this paper
• Desferrioxamine in acute iron poisoning.

  1992cited by this paper
• Desferrioxamine in acute iron poisoning.

  1992cited by this paper
• Pulmonary toxic effects of continuous desferrioxamine administration in acute iron poisoning.

  1992cited by this paper
• The role of iron in oxygen-mediated toxicities.

  1992cited by this paper
• Desferrioxamine in acute iron poisoning.

  1992cited by this paper
• Pulmonary toxicity of deferoxamine in children with advanced cancer.

  1991cited by this paper
• Deferoxamine (Desferrioxamine)

  1991cited by this paper
• Pulmonary syndrome and intravenous high-dose desferrioxamine.

  1990cited by this paper
• Pulmonary syndrome in patients with thalassemia major receiving intravenous deferoxamine infusions.

  1990cited by this paper
• Protection against tissue damage in vivo by desferrioxamine: what is its mechanism of action?

  1989cited by this paper
• Desferrioxamine ototoxicity: evaluation of risk factors in thalassaemic patients and guidelines for safe dosage

  1989cited by this paper
• Hemodynamic effects of experimental iron poisoning.

  1989cited by this paper
• Ocular toxicity of desferrioxamine--an example of copper promoted auto-oxidative damage?

  1989cited by this paper
• Irreversible ocular toxicity from single "challenge" dose of deferoxamine.

  1989cited by this paper
• Iron-chelating therapy.

  1988cited by this paper
• Ocular toxicity after a single intravenous dose of desferrioxamine in 2 hemodialyzed patients.

  1987cited by this paper
• Iron sepsis: Yersinia enterocolitica septicemia possibly caused by an overdose of iron.

  1987cited by this paper
• Pneumocystis carinii choroiditis in a male homosexual with AIDS and disseminated pulmonary and extrapulmonary P. carinii infection.

  1987cited by this paper
• Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions.

  1986cited by this paper
• Effects of iron and desferrioxamine on infections with Yersinia enterocolitica

  1985cited by this paper
• Cerebral and ocular toxicity induced by desferrioxamine.

  1985cited by this paper
• [4] Role of iron in oxygen radical reactions

  1984cited by this paper
• Desferrioxamine, ocular toxicity, and trace metals.

  1983cited by this paper
• Ocular toxicity of high-dose intravenous desferrioxamine.

  1983cited by this paper
• Septicaemia due to Yersinia enterocolitica after oral overdoses of iron.

  1982cited by this paper
• Rapid desensitisation for desferrioxamine anaphylactic reaction.

  1981cited by this paper
• Rapid desensitisation for desferrioxamine anaphylactic reaction.

  1981cited by this paper
• Studies in Desferrioxamine and Ferrioxamine Metabolism in Normal and Iron‐Loaded Subjects

  1979cited by this paper
• Reassessment of the use of desferrioxamine B in iron overload.

  1976cited by this paper
• Studies in Acute Iron Poisoning III. The Hemodynamic Alterations in Acute Experimental Iron Poisoning

  1968cited by this paper
• Chelation therapy in acute iron poisoning.

  1967cited by this paper
• Distribution and renal excretion of desferrioxamine and ferrioxamine in the dog and in the rat.

  1966cited by this paper
• Deferoxamine in the Treatment of Acute Iron Poisoning

  1966cited by this paper
• Studies in acute iron poisoning. II. Further observations on desferrioxamine in the treatment of acute experimental iron poisoning.

  1966cited by this paper
• Studies in acute iron poisoning. I. Desferrioxamine in the treatment of acute iron poisoning: clinical observations, experimental studies, and theoretical considerations.

  1965cited by this paper
• The Biochemistry of Desferrioxamine and its Relation to Iron Metabolism

  1964cited by this paper
• Report of Three Cases

  1962cited by this paper
• A review of the toxicity of iron compounds.

  1955cited by this paper
• Acute intestinal iron intoxication. I. Iron absorption, serum iron and autopsy findings.

  1955cited by this paper
• The liver in ferrous sulfate poisoning; a report of three fatal cases in children and an experimental study.

  1954cited by this paper
• Ferrous sulfate poisoning; report of three cases.

  1952cited by this paper
• Death following ingestion of ferrous sulfate.

  1948cited by this paper
• Ferrous Sulphate Poisoning

  1947cited by this paper

• Acute Iron Poisoning: A Case of Fulminant Hepatic Failure.

  2024cites this paper
• Characteristics and outcome of 73 dogs with iron EDTA molluscicide ingestion in Melbourne, Australia (2013-2019).

  2024cites this paper
• Effect of Deferoxamine on Post-Transfusion Iron, Inflammation, and In Vitro Microbial Growth in a Canine Hemorrhagic Shock Model: A Randomized Controlled Blinded Pilot Study

  2023cites this paper
• Current status of the applications of conditioned media derived from mesenchymal stem cells for regenerative medicine.

  2023cites this paper
• Targeting ferroptosis: a novel insight against myocardial infarction and ischemia–reperfusion injuries

  2022cites this paper
• Joint Cardioprotective Effect of Vitamin C and Other Antioxidants against Reperfusion Injury in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

  2021cites this paper
• Mechanisms of Intranasal Deferoxamine in Neurodegenerative and Neurovascular Disease

  2021cites this paper
• Hyperferritinemia in patients with COVID-19: An opportunity for iron chelation?

  2020cites this paper
• Efficacy of Intravenous N-acetylcysteine as an Adjuvant Antioxidant Therapy in Acute Iron Toxicity in Rats

  2020cites this paper
• Human adipose-derived mesenchymal stem cell-conditioned medium ameliorates polyneuropathy and foot ulceration in diabetic BKS db/db mice

  2020cites this paper
• Iron overdose epidemiology, clinical features and iron concentration-effect relationships: the UK experience 2008–2017

  2018cites this paper
• Preconditioning of adipose tissue-derived mesenchymal stem cells with deferoxamine increases the production of pro-angiogenic, neuroprotective and anti-inflammatory factors: Potential application in the treatment of diabetic neuropathy

  2017cites this paper
• Pharmacological priming of adipose‐derived stem cells for paracrine VEGF production with deferoxamine

  2016cites this paper
• Immunoliposomes for Targeted Delivery of an Antifibrotic Drug.

  2015cites this paper
• Pharmacological Suppression of CNS Scarring by Deferoxamine Reduces Lesion Volume and Increases Regeneration in an In Vitro Model for Astroglial-Fibrotic Scarring and in Rat Spinal Cord Injury In Vivo

  2015cites this paper
• Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury.

  2013cites this paper
• 3 Metals, oxidative stress and neurodegeneration: A focus on iron, manganese

  2012cites this paper
• Iron Poisoning: A Literature-Based Review of Epidemiology, Diagnosis, and Management

  2011cites this paper
• Evaluation and Management of Toxicological Emergencies

  2010cites this paper
• Iron as a Drug and Drug–Drug Interactions

  2009cites this paper
• Current views on antidotal therapy in managing cases of poisoning and overdose.

  2008cites this paper
• Intoxicaciones por hierro y otros metales

  2008cites this paper
• Chapter 179 – Toxicity of Over-the-Counter and Oral Hypoglycemic Agents

  2007cites this paper
• Acute iron poisoning in adult female

  2007cites this paper
• SESAME OIL ATTENUATES ACUTE IRON-INDUCED LIPID PEROXIDATION-ASSOCIATED HEPATIC DAMAGE IN MICE

  2006cites this paper
• Cell Permeable Iron Chelators as Potential Cancer Chemotherapeutic Agents

  2005cites this paper
• Chelators as antidotes of metal toxicity: therapeutic and experimental aspects.

  2005cites this paper
• PITFALLS IN THE MANAGEMENT OF THE POISONED PATIENT

  2003cites this paper
• Desferri-exochelin induces death by apoptosis in human breast cancer cells but does not kill normal breast cells

  2001cites this paper
• Deferoxamine toxicity in hepatoma and primary rat cortical brain cultures

  2001cites this paper
• Comparative effects of metal chelating agents on the neuronal cytotoxicity induced by copper (Cu+2), iron (Fe+3) and zinc in the hippocampus.

  2001cites this paper
• Acute respiratory distress syndrome in children with acute iron poisoning: the role of intravenous desferrioxamine

  2000cites this paper
• Iron poisoning.

  2000cites this paper
• An Exochelin of Mycobacterium tuberculosis Reversibly Arrests Growth of Human Vascular Smooth Muscle Cells in Vitro *

  2000cites this paper
• Intoxications par le fer

  1999cites this paper
• Los antídotos: el centro antitóxico como botiquín de referencia

  1999cites this paper
• Lack of protective effects of dietary silicon on aluminium-induced maternal and developmental toxicity in mice.

  1999cites this paper
• Common Culprits in Childhood Poisoning

  1999cites this paper
• Chelation therapy in aluminum-loaded rats: influence of age.

  1999cites this paper
• Differential regulation of human alveolar macrophage-derived interleukin-1beta and tumor necrosis factor-alpha by iron.

  1998cites this paper
• A fatal case of acute ferric chloride poisoning.

  1998cites this paper
• Differential regulation of human alveolar macrophage-derived interleukin-1β and tumor necrosis factor-α by iron

  1998cites this paper
• Serum Iron Concentrations and Symptoms of Acute Iron Poisoning in Children

  1996cites this paper